Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain

Assiut University60 enrolled

Overview

fluoroscopic group \& includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group \& includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

Conditions

Intractable Pelvic Cancer Pain

Interventions

fluroscopic guided blockPROCEDURE

SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.

double modality (ultrasound and fluroscopic) guided blockPROCEDURE

SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position. Then C-arm pictures will be checked (both P-A \& dead lateral)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years. * Intractable pelvic cancer pain (VAS \> 40 mm) * Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids' side effects are not tolerated. Exclusion criteria * Local or systemic sepsis. * Uncorrectable coagulopathy. * Neuropsychiatric illness. * History of drug abuse. * Pregnant or lactating patients. * Distorted local anatomy. * Patients who are known to be allergic to the used medications. * Cardiovascular or respiratory instability.

Locations (1)

NCI, Cairo university

Cairo, Egypt

Outcomes

Primary Outcomes

pain relief will be assessed by VAS

pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain \& right (10) end means the worst possible pain

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.